Latest stories on IPHA
Innate and Sobi Announce Partnership Is Now Effective Following Completion of Closing Conditions
StockTitan66 · bullishproduct/pr
Innate Pharma, Grove, and more set to report earnings Thursday
Investing.com Markets50 · neutralearnings
Innate Pharma to Participate in the H.C. Wainwright 28th Annual Global Investment Conference
StockTitan55 · neutralgeneral
Innate Pharma S.A. (IPHA) Discusses EUR 30 Million Equity Raise, Strategic Partnership and Pipeline Advancement Transcript
Seeking Alpha28 · bearishgeneral
Innate Pharma Announces Conference Call and Webcast
StockTitan50 · neutralgeneral
At a glance: stocks gapping up premarket
Seeking Alpha63 · neutralgeneral
Leerink Upgrades Innate Pharma To Outperform After Lacutamab Deal
The Fly61 · neutralanalyst
Innate Pharma Upgraded To Outperform From Market Perform At Leerink
The Fly61 · neutralanalyst
Innate Pharma Price Target Raised To 7 From 5 At H C Wainwright
The Fly61 · neutralanalyst
IPHA Strikes Major $580 Million Licensing Deal With Sobi for Lacutamab—Accelerated Approval Path in T-Cell Lymphoma Gains Momentum
August 10, 2026
MarketChameleon78 · bullishproduct/pr
At a glance: stocks gapping up premarket
Seeking Alpha63 · neutralgeneral
Innate Pharma Cmo Sonia Quaratino To Depart Markus Jensen To Succeed
The Fly34 · bearishgeneral
Innate Pharma, Sobi to enable initiation of the TELLOMAK-3 study
The Fly56 · neutralproduct/pr
Sobi enters strategic partnership with Innate Pharma to license lacutamab in T-cell lymphoma
PR Newswire66 · bullishproduct/pr
Innate Pharma to Advance Lacutamab Towards Phase 3 Following Partnership With Sobi and Appoints New Chief Medical Officer
StockTitan63 · neutralproduct/pr
Innate Pharma Enters Strategic Partnership With Sobi to License Lacutamab in T-cell Lymphoma
StockTitan63 · neutralproduct/pr
Innate Pharma: Pipeline Optionality Favors Speculative Bulls At These Levels
Seeking Alpha63 · neutralanalyst
Innate Pharma to Participate in a Bladder Cancer Panel at the BTIG Virtual Biotechnology Conference
StockTitan56 · neutralproduct/pr
Outcome of Innate Pharma’s 2026 Annual General Meeting | IPHA Stock News
StockTitan50 · neutralgeneral
Innate Pharma S.A. 2026 Q1 - Results - Earnings Call Presentation
Seeking Alpha50 · neutralearnings